The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPjsc Tatneft Regulatory News (ATAD)

  • This share is currently suspended. It was suspended at a price of 2.35

Share Price Information for Pjsc Tatneft (ATAD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.35
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.35
ATAD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Approves New Strategy

26 Sep 2018 13:51

RNS Number : 0392C
PJSC Tatneft
26 September 2018
 

26 September 2018

 

Tatneft's Board of Directors Approved the Company's Development Strategy for the Period until 2030

A regular meeting of TATNEFT Board of Directors chaired by R.N. Minnikhanov, President of the Republic of Tatarstan, was held in Kazan (Republic of Tatarstan) on September 26, 2018

The meeting considered the execution of the Company's budget for eight months of 2018 and approved budgets for October and the fourth quarter of the current year.

The Board of Directors approved the goals of TATNEFT Group Development Strategy until 2030. Key parameters of the Strategy are: to increase crude oil production to 38.4 million tonnes per year by 2030 with a 100% reserves replacement, a gradual increase in the volume of crude oil refining to 15.3 million tonnes per year, ensuring maximization of economic benefits from the operation of the TANECO complex, annual sales of 18 million tires, construction of the first stage of the new gas and petrochemical complex. In aggregate successful achievement of the business goals in the base case scenario, based on the economic forecasts of the Government of the Republic of Tatarstan and the Ministry of Economic Development of Russia will allow increasing the Group's capitalization to $36 billion, while ensuring the annual dividend payments to shareholders in accordance with the Company's dividend policy, maintaining leadership positions in the environment protection area, and developing the human capital. The main parameters of the strategy have been published on the Company's official Internet website at:

http://www.tatneft.ru/for-shareholders/information-disclosure/presentations-to-investors?lang=en

At the meeting the Board of Directors discussed the information on the KPIs (key performance indicators) system implementation within the TATNEFT Group. Implementation of the pilot project in 2017 allowed converting the strategic goals into annual measurable indicators, conducting a transparent assessment of the key employees' work results, promoting identification of inefficiencies in the management processes and outlining new areas for further development. In the current year TATNEFT has moved on to the next stage of the KPI system development: increasing the number of employees in the main business areas and involving such functionalities as innovational activities, IT, HR, corporate management, etc.

In accordance with the Company's Charter, the Board of Directors, in reliance on the recommendation of the Board's compensation committee, extended the term of duties of N.U. Maganov as the General Director of PJSC TATNEFT for a period of five years in connection with the expiry of his current term, with effect from November 26, 2018. The powers of Valery D. Ershov, member of the PJSC TATNEFT's Management Council, were terminated in connection with his the retirement.

This press-releases contains inside information.

 

 

Forward-looking statements: These materials contain statements about future events and expectations that are forward-looking in nature. Any statement in these materials that is not a statement of historical fact is a forward-looking statement that involves known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements expressed or implied by such forward-looking statements to differ. PJSC TATNEFT assumes no obligations to update the forward-looking statements contained herein to reflect actual results, changes in assumptions or changes in factors affecting these statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAANKALXPEFF
Date   Source Headline
29th Dec 202311:41 amRNSEGM Approves Dividends for 9m 2023
21st Nov 20233:18 pmRNSTatneft EGM to approve 9m 2023 dividend
29th Sep 20239:42 amRNSTatneft EGM approves 6m 2023 dividend
15th Aug 20233:21 pmRNSBoard of Directors 1H 2023 div and EGM decisions
30th Jun 20232:44 pmRNSPJSC Tatneft AGM Results
19th Jun 20238:33 amRNSNotice of AGM
27th Apr 202312:20 pmRNSAGM Notice and Dividend Recommendation
30th Mar 20232:15 pmRNSAcquisition of business from Nokian Tyres plc
20th Mar 20237:00 amRNSTatneft's Annual IFRS and Directors' Report
28th Dec 20227:00 amRNSResult of EGM
16th Nov 20227:24 amRNSBoard Recommends Dividends for 9m2022
28th Oct 20224:16 pmRNSTatneft to acquire Russian assets of Nokian Tyres
23rd Sep 202210:09 amRNSTatneft EGM Approves Dividends for 1H2022
30th Aug 20227:00 amRNSTatneft publishes IFRS results for 1H2022
16th Aug 20229:52 amRNSBoard convenes EGM and recommends dividends 1H2022
9th Aug 202211:42 amRNSNew Legal Regime for ADR Holders
24th Jun 20224:35 pmRNSResult of AGM
15th Jun 20223:29 pmRNSPayments to Governments Report 2021
31st May 20229:45 amRNSStatement regarding 1Q 2022 IFRS accounts
23rd May 20222:40 pmRNSBoard Recommends Dividends
17th May 202210:32 amRNSTatneft Obtained Permit to Continue ADR Program
16th May 20228:46 amRNSTatneft Sells Tire Business
29th Apr 20222:04 pmRNSBoard Reapproves Nominations to the Board
27th Apr 202212:28 pmRNSNotice to ADR Holders
25th Apr 20225:24 pmRNSBoard Approves AGM Agenda, Related Issues
19th Apr 202211:10 amRNSLaw Affecting ADR Program - Correction
19th Apr 20229:22 amRNSLaw Affecting ADR Program
1st Apr 20223:10 pmRNSDraft Law; Rating Withdrawal
15th Mar 20228:31 amRNSAnnual Financial Report
14th Mar 202210:06 amRNSStatement regarding Ratings
10th Mar 20223:18 pmRNSBoard Approves Nominations
2nd Mar 20224:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:36 pmRNSPrice Monitoring Extension
1st Mar 20224:43 pmRNSSecond Price Monitoring Extn
1st Mar 20224:37 pmRNSPrice Monitoring Extension
28th Feb 20224:41 pmRNSSecond Price Monitoring Extn
28th Feb 20224:37 pmRNSPrice Monitoring Extension
30th Dec 20211:34 pmRNSResult of EGM - Dividends
20th Dec 20219:26 amRNSNew Committee of the Board
30th Nov 202112:35 pmRNSPresentation to Investors
29th Nov 20217:32 amRNS3rd Quarter Results
23rd Nov 20218:03 amRNSBoard Recommends 3Q Dividends
1st Oct 202110:05 amRNSDividend Declaration
27th Aug 20217:25 amRNSHalf-year Report
26th Aug 202110:19 amRNSBoard convenes EGM, recommends dividends
1st Jul 20217:00 amRNSFirst Board Meeting and Board Committees Election
30th Jun 20215:15 pmRNSPayments to Governments Report
25th Jun 20215:10 pmRNSResult of AGM
9th Jun 20212:37 pmRNSAcquisition of EkoPet
4th Jun 20217:30 amRNS1st Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.